149 related articles for article (PubMed ID: 19914249)
1. Neuronal nicotinic acetylcholine receptor-cholesterol crosstalk in Alzheimer's disease.
Barrantes FJ; Borroni V; Vallés S
FEBS Lett; 2010 May; 584(9):1856-63. PubMed ID: 19914249
[TBL] [Abstract][Full Text] [Related]
2. The role of nicotinic acetylcholine receptors in Alzheimer's disease.
Oddo S; LaFerla FM
J Physiol Paris; 2006; 99(2-3):172-9. PubMed ID: 16448808
[TBL] [Abstract][Full Text] [Related]
3. Alpha7 neuronal nicotinic receptors: the missing link to understanding Alzheimer's etiopathology?
Bencherif M; Lippiello PM
Med Hypotheses; 2010 Feb; 74(2):281-5. PubMed ID: 19800174
[TBL] [Abstract][Full Text] [Related]
4. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease.
Pákáski M; Kálmán J
Neurochem Int; 2008 Nov; 53(5):103-11. PubMed ID: 18602955
[TBL] [Abstract][Full Text] [Related]
5. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease.
Gouras GK; Almeida CG; Takahashi RH
Neurobiol Aging; 2005 Oct; 26(9):1235-44. PubMed ID: 16023263
[TBL] [Abstract][Full Text] [Related]
6. Neuronal nicotinic acetylcholine receptors serve as sensitive targets that mediate beta-amyloid neurotoxicity.
Liu Q; Wu J
Acta Pharmacol Sin; 2006 Oct; 27(10):1277-86. PubMed ID: 17007734
[TBL] [Abstract][Full Text] [Related]
7. Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment.
Lombardo S; Maskos U
Neuropharmacology; 2015 Sep; 96(Pt B):255-62. PubMed ID: 25514383
[TBL] [Abstract][Full Text] [Related]
8. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.
Teaktong T; Graham AJ; Court JA; Perry RH; Jaros E; Johnson M; Hall R; Perry EK
J Neurol Sci; 2004 Oct; 225(1-2):39-49. PubMed ID: 15465084
[TBL] [Abstract][Full Text] [Related]
9. The consequences of reducing expression of the alpha7 nicotinic receptor by RNA interference and of stimulating its activity with an alpha7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease.
Qi XL; Nordberg A; Xiu J; Guan ZZ
Neurochem Int; 2007; 51(6-7):377-83. PubMed ID: 17493709
[TBL] [Abstract][Full Text] [Related]
10. Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease.
Fuentealba RA; Farias G; Scheu J; Bronfman M; Marzolo MP; Inestrosa NC
Brain Res Brain Res Rev; 2004 Dec; 47(1-3):275-89. PubMed ID: 15572177
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease: the cholesterol connection.
Puglielli L; Tanzi RE; Kovacs DM
Nat Neurosci; 2003 Apr; 6(4):345-51. PubMed ID: 12658281
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholinergic neurotransmission and the beta-amyloid cascade: implications for Alzheimer's disease.
Verhoeff NP
Expert Rev Neurother; 2005 Mar; 5(2):277-84. PubMed ID: 15853497
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol and pathological processes in Alzheimer's disease.
Yanagisawa K
J Neurosci Res; 2002 Nov; 70(3):361-6. PubMed ID: 12391598
[TBL] [Abstract][Full Text] [Related]
14. Does cholesterol act as a protector of cholinergic projections in Alzheimer's disease?
Bohr IJ
Lipids Health Dis; 2005 Jun; 4():13. PubMed ID: 15949039
[TBL] [Abstract][Full Text] [Related]
15. Methylene blue and Alzheimer's disease.
Oz M; Lorke DE; Petroianu GA
Biochem Pharmacol; 2009 Oct; 78(8):927-32. PubMed ID: 19433072
[TBL] [Abstract][Full Text] [Related]
16. Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
Wenk GL
J Clin Psychiatry; 2006; 67 Suppl 3():3-7; quiz 23. PubMed ID: 16649845
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk between oxidative stress and modifications of cholinergic and glutaminergic receptors in the pathogenesis of Alzheimer's disease.
Guan ZZ
Acta Pharmacol Sin; 2008 Jul; 29(7):773-80. PubMed ID: 18565274
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease is associated with a selective increase in alpha7 nicotinic acetylcholine receptor immunoreactivity in astrocytes.
Teaktong T; Graham A; Court J; Perry R; Jaros E; Johnson M; Hall R; Perry E
Glia; 2003 Jan; 41(2):207-11. PubMed ID: 12509811
[TBL] [Abstract][Full Text] [Related]
19. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease.
Gómez-Isla T; Hollister R; West H; Mui S; Growdon JH; Petersen RC; Parisi JE; Hyman BT
Ann Neurol; 1997 Jan; 41(1):17-24. PubMed ID: 9005861
[TBL] [Abstract][Full Text] [Related]
20. [Neurofibrillary tangles and early modification of the neuronal cytoskeleton in Alzheimer's disease and in experimental models].
Brion JP
Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):287-94. PubMed ID: 10992876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
